fructosamine has been researched along with Cholera Infantum in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allavoine, T; Howlett, H; Lehert, P; Marre, M | 1 |
| Bailey, WL; Jones, MR; Kalin, MF; Schwartz, SL; Zieve, FJ | 1 |
2 trial(s) available for fructosamine and Cholera Infantum
| Article | Year |
|---|---|
Improved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance) in Type 2 diabetic patients inadequately controlled on metformin.
Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Fructosamine; Gastrointestinal Diseases; Glyburide; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Tablets; Treatment Outcome | 2002 |
Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.
Topics: Aged; Allylamine; Anticholesteremic Agents; Apolipoproteins B; Blood Glucose; Cholesterol; Cholesterol, LDL; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fructosamine; Gastrointestinal Diseases; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Middle Aged; Pilot Projects | 2007 |